|
XRCC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.578190E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.600520E-03 |
| Normal-vs-Stage2 |
9.966200E-02 |
| Normal-vs-Stage3 |
4.343700E-02 |
| Normal-vs-Stage4 |
1.935900E-02 |
| Stage1-vs-Stage2 |
8.459200E-01 |
| Stage1-vs-Stage3 |
4.679800E-01 |
| Stage1-vs-Stage4 |
9.955200E-01 |
| Stage2-vs-Stage3 |
8.060600E-01 |
| Stage2-vs-Stage4 |
8.692200E-01 |
| Stage3-vs-Stage4 |
6.264400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.062950E-03 |
| Normal-vs-AfricanAmerican |
6.015800E-03 |
| Normal-vs-Asian |
5.893600E-02 |
| Caucasian-vs-AfricanAmerican |
1.024970E-01 |
| Caucasian-vs-Asian |
6.091200E-01 |
| AfricanAmerican-vs-Asian |
8.926100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.177200E-04 |
| Normal-vs-Female |
7.160500E-03 |
| Male-vs-Female |
1.047570E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.055300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.561590E-03 |
| Normal-vs-Age(61-80Yrs) |
1.058410E-01 |
| Normal-vs-Age(81-100Yrs) |
6.305600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.407600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.568800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.978000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.539010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.436000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.565600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.103840E-02 |
| Classical-VS-Follicular |
1.603510E-02 |
| Classical-VS-Other |
4.501200E-01 |
| Classical-VS-Normal |
6.36450000000011E-05 |
| Tall-VS-Follicular |
5.191800E-01 |
| Tall-VS-Other |
1.815010E-01 |
| Tall-VS-Normal |
8.558000E-01 |
| Follicular-VS-Other |
1.810440E-01 |
| Follicular-VS-Normal |
3.575400E-01 |
| Other-VS-Normal |
1.637380E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.603900E-03 |
| Normal-vs-N1 |
1.762760E-01 |
| N0-vs-N1 |
3.249800E-01 |
|
|
